To address the role of the neuroblastoma-specific oncogene MYCN, which cooperates with activated ALK during neuroblastoma pathogenesis [33, 34], the inducible IMR5/75 (ALK-amplified) shMYCN knockdown system was utilized [35]. Here, MYCN is linked to neuroblastoma.